- Report
- June 2024
- 200 Pages
Global
From €7243EUR$7,950USD£6,290GBP
- Report
- October 2024
- 196 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- March 2025
- 183 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 194 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 190 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- October 2024
- 187 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- July 2024
- 220 Pages
Global
From €5421EUR$5,950USD£4,707GBP
- Report
- February 2025
- 200 Pages
Global
From €4091EUR$4,490USD£3,552GBP
- Report
- March 2025
- 200 Pages
Global
From €4091EUR$4,490USD£3,552GBP
- Report
- March 2025
- 200 Pages
Global
From €4091EUR$4,490USD£3,552GBP
- Report
- March 2025
- 150 Pages
Global
From €4419EUR$4,850USD£3,837GBP
- Report
- May 2024
- 131 Pages
Global
From €5921EUR$6,499USD£5,142GBP
- Report
- May 2024
- 131 Pages
Global
From €5921EUR$6,499USD£5,142GBP
- Report
- June 2024
- 260 Pages
Global
From €7243EUR$7,950USD£6,290GBP
- Clinical Trials
- November 2024
- 80 Pages
Global
From €1822EUR$2,000USD£1,582GBP
- Drug Pipelines
- June 2024
- 80 Pages
Global
From €1822EUR$2,000USD£1,582GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1367EUR$1,500USD£1,187GBP
- Report
- March 2025
- 180 Pages
Global
From €4100EUR$4,500USD£3,560GBP
- Report
- March 2025
- 185 Pages
Global
From €4100EUR$4,500USD£3,560GBP
- Report
- March 2024
- 150 Pages
Global
From €5421EUR$5,950USD£4,707GBP

Diabetic Neuropathy is a type of nerve damage caused by diabetes. It is a common complication of diabetes, affecting up to 70% of people with the condition. Symptoms of diabetic neuropathy can include pain, numbness, tingling, and loss of sensation in the feet, legs, and hands. It can also cause problems with balance and coordination, as well as digestive issues. Endocrinologists are medical professionals who specialize in the diagnosis and treatment of endocrine disorders, including diabetes. They are well-equipped to diagnose and treat diabetic neuropathy, as well as provide lifestyle advice to help manage the condition.
Companies in the Diabetic Neuropathy market include Novartis, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more